Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients

Transplantation Reviews

Volumn 24, Issue 3, 2010, Pages 121-128

  Canaud, Guillaume ^a,b   Martinez, Frank ^a,b   Noël, Laure Hélène ^b   Mamzer, Marie France ^a,b   Niaudet, Patrick ^a,b   Legendre, Christophe ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GALACTOSE; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RETINOIC ACID; ROSCOVITINE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; CYCLOSPORIN;

CLINICAL TRIAL; CYTOSKELETON; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; GRAFT RECIPIENT; HUMAN; IMMUNOADSORPTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PODOCYTE; PROTEIN URINE LEVEL; PROTEINURIA; RECURRENT DISEASE; REVIEW; URINARY EXCRETION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; PATHOPHYSIOLOGY; RISK FACTOR;

CYCLOSPORINE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; PLASMA EXCHANGE; RECURRENCE; RISK FACTORS; STEROIDS;

EID: 77954382504     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2010.04.001     Document Type: Review

References (65)

1. Habib R., Levy M., Gubler M.C. Clinicopathologic correlations in the nephrotic syndrome. Paediatrician 1979, 8:325-348.
2. Cameron J.S. The enigma of focal segmental glomerulosclerosis. Kidney Int Suppl 1996, 57:S119-S131.
3. Haas M., Meehan S.M., Karrison T.G., Spargo B.H. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997, 30:621-631.
4. Braden G.L., Mulhern J.G., O'Shea M.H., Nash S.V., Ucci A.A., Germain M.J. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000, 35:878-883.
5. Kitiyakara C., Eggers P., Kopp J.B. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004, 44:815-825.
6. Filler G., Young E., Geier P., Carpenter B., Drukker A., Feber J. Is there really an increase in non-minimal change nephrotic syndrome in children?. Am J Kidney Dis 2003, 42:1107-1113.
7. Cameron J.S., Senguttuvan P., Hartley B., et al. Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. Transplant Proc 1989, 21:2117-2118.
8. Dantal J., Baatard R., Hourmant M., Cantarovich D., Buzelin F., Soulillou J.P. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 1991, 52:827-831.
9. Ingulli E., Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation 1991, 51:401-405.
10. Dantal J., Soulillou J.P. Relapse of focal segmental glomerulosclerosis after kidney transplantation. Adv Nephrol Necker Hosp 1996, 25:91-106.
11. Tejani A., Stablein D.H. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American pediatric renal transplant cooperative study. J Am Soc Nephrol 1992, 2(12 Suppl):S258-S263.
12. Artero M.L., Sharma R., Savin V.J., Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994, 23:574-581.
13. Pardon A., Audard V., Caillard S., et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006, 21:1053-1059.
14. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996, 334:878-883.
15. Dantal J., Bigot E., Bogers W., et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994, 330:7-14.
16. Artero M., Biava C., Amend W., Tomlanovich S., Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992, 92:375-383.
17. Shalhoub R.J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974, 2:556-560.
18. Sahali D., Pawlak A., Valanciute A., et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 2002, 13:1238-1247.
19. Grimbert P., Valanciute A., Audard V., et al. Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 2003, 198:797-807.
20. Yap H.K., Cheung W., Murugasu B., Sim S.K., Seah C.C., Jordan S.C. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999, 10:529-537.
21. Lai K.W., Wei C.L., Tan L.K., et al. Overexpression of interleukin-13 induces minimal- change-like nephropathy in rats. J Am Soc Nephrol 2007, 18:1476-1485.
22. Bruneau S., Le Berre L., Herve C., et al. Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation. Am J Kidney Dis 2009, 54:522-532.
23. Sellier-Leclerc A.L., Duval A., Riveron S., et al. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol 2007, 18:2732-2739.
24. Pescovitz M.D., Book B.K., Sidner R.A. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006, 354:1961-1963.
25. Hoyer J.R., Vernier R.L., Najarian J.S., Raij L., Simmons R.L., Michael A.F. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972, 2:343-348.
26. Zimmerman S.W. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 1984, 22:32-38.
27. Lagrue G., Branellec A., Niaudet P., Heslan J.M., Guillot F., Lang P. Transmission of nephrotic syndrome to two neonates. Spontaneous regression. Presse Med 1991, 20:255-257.
28. Dantal J., Godfrin Y., Koll R., et al. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 1998, 9:1709-1715.
29. Savin V.J., McCarthy E.T., Sharma R., Charba D., Sharma M. Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 2008, 151:288-292.
30. Kim B.K., Hong H.K., Kim J.H., Lee H.S. Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis 2002, 40:964-973.
31. Canaud G., Bruneval P., Noel L.H., et al. Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries. Am J Kidney Dis 2010, 55:558-565.
32. Bariety J., Nochy D., Mandet C., Jacquot C., Glotz D., Meyrier A. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998, 53:918-925.
33. Dijkman H.B., Weening J.J., Smeets B., et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 2006, 70:338-344.
34. Reiser J., von Gersdorff G., Loos M., et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004, 113:1390-1397.
35. Raafat R., Travis L.B., Kalia A., Diven S. Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatric Nephrol 2000, 14:189-194.
36. Gagnadoux M.F. Ask the expert. Does antibody induction therapy with daclizumab or basiliximab increase the risk of recurrence of post-transplant focal segmental glomerulosclerosis?. Pediatric Nephrol 2002, 17:305.
37. Hubsch H., Montane B., Abitbol C., et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatric Nephrol 2005, 20:210-216.
38. Laufer J., Ettenger R.B., Ho W.G., Cohen A.H., Marik J.L., Fine R.N. Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 1988, 46:540-542.
39. Ingulli E., Tejani A., Butt K.M., et al. High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation. Transplantation 1990, 49:219-221.
40. Cochat P., Kassir A., Colon S., et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmapheresis and cyclophosphamide. Pediatric Nephrol 1993, 7:50-54.
41. Dall'Amico R., Ghiggeri G., Carraro M., et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999, 34:1048-1055.
42. Cheong H.I., Han H.W., Park H.W., et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000, 15:78-81.
43. Salomon R., Gagnadoux M.F., Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003, 75:810-814.
44. Raafat R.H., Kalia A., Travis L.B., Diven S.C. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004, 44:50-56.
45. Deegens J.K., Andresdottir M.B., Croockewit S., Wetzels J.F. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl Int 2004, 17:151-157.
46. Valdivia P., Gonzalez Roncero F., Gentil M.A., et al. Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant. Transplant Proc 2005, 37:1473-1474.
47. McCauley J., Shapiro R., Ellis D., Igdal H., Tzakis A., Starzl T.E. Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993, 8:1286-1290.
48. Kessler M., Champigneulles J., Hestin D., Frimat L., Renoult E. A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. Transplantation 1999, 67:641-643.
49. Bussemaker E., Passauer J., Franz T., Gross P. Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome. Nephrol Dial Transplant 2001, 16:1270-1272.
50. Canaud G., Zuber J., Sberro R., et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant 2009, 9:1081-1086.
51. Wada T., Pippin J.W., Marshall C.B., Griffin S.V., Shankland S.J. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 2005, 16:2615-2625.
52. Ransom R.F., Lam N.G., Hallett M.A., Atkinson S.J., Smoyer W.E. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 2005, 68:2473-2483.
53. Faul C., Donnelly M., Merscher-Gomez S., et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nature Med 2008, 14:931-938.
54. Canaud G., Dion D., Zuber J., et al. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 2010, 25:1321-1328.
55. Gohh R.Y., Yango A.F., Morrissey P.E., et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005, 5:2907-2912.
56. Gossmann J., Scheuermann E.H., Porubsky S., Kachel H.G., Geiger H., Hauser I.A. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 2007, 20:558-562.
57. Hristea D., Hadaya K., Marangon N., et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007, 20:102-105.
58. Kamar N., Faguer S., Esposito L., et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007, 67:250-254.
59. Yabu J.M., Ho B., Scandling J.D., Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008, 8:222-227.
60. Leandro M.J., Cambridge G., Edwards J.C., Ehrenstein M.R., Isenberg D.A. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) 2005, 44:1542-1545.
61. Le Berre L., Herve C., Buzelin F., Usal C., Soulillou J.P., Dantal J. Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int 2005, 68:2079-2090.
62. Bakr A., Shokeir M., El-Chenawi F., El-Husseni F., Abdel-Rahman A., El-Ashry R. Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatric Nephrol 2003, 18:516-520.
63. Leroy S., Guigonis V., Bruckner D., et al. Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 2009, 9:858-861.
64. He J.C., Lu T.C., Fleet M., et al. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol 2007, 18:93-102.
65. De Smet E., Rioux J.P., Ammann H., Deziel C., Querin S. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy. Nephrol Dial Transplant 2009, 24:2938-2940.